Brief: Eton Terminated Asset Purchase Deal With Wellstat Therapeutics Corp & Wellstat Biologics Corp
05/07/2023 21:20
July 5 (Reuters) - Eton Pharmaceuticals Inc ETON.O :
* ETON PHARMACEUTICALS- ON JUNE 30, CO TERMINATED ASSET
PURCHASE
DEAL WITH WELLSTAT THERAPEUTICS CORPORATION AND WELLSTAT
BIOLOGICS CORPORATION
Source text for Eikon: ID:
Further company coverage: ETON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer